...
首页> 外文期刊>International Journal of Cardiology >Statins and atrial fibrillation in patients with left ventricular dysfunction: Insights from the AF-CHF trial
【24h】

Statins and atrial fibrillation in patients with left ventricular dysfunction: Insights from the AF-CHF trial

机译:左心功能不全患者的他汀类药物和心房颤动:AF-CHF试验的启示

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

It has been speculated that statins, by virtue of their pleiotropic antioxidant and anti-inflammatory properties, may protect against new onset atrial fibrillation (AF), decrease the risk of recurrent AF, and delay transition of paroxysmal to permanents forms. However, there is a paucity of data regarding the effect of statins on AF in the setting of congestive heart failure (CHF). We, therefore, assessed the impact of statins on overall AF burden and recurrent AF in patients with CHF.
机译:据推测,他汀类药物由于其多效抗氧化剂和抗炎特性,可以预防新发的心房颤动(AF),降低复发性AF的风险,并延缓阵发性转变为永久性形式。然而,在充血性心力衰竭(CHF)的情况下,关于他汀类药物对房颤的影响的数据很少。因此,我们评估了他汀类药物对CHF患者总体房颤负担和复发性房颤的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号